Loose body following cross-pin fixation for anterior cruciate ligament reconstruction

por Boden, R. A., Razak, A., Hussain, S. M. A., Mcloughlin, S. J.
Publicado 2012

Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.

por Pedley, R. B., Boden, J. A., Boden, R., Dale, R., Begent, R. H.
Publicado 1993

Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.

por Marshall, D., Pedley, R. B., Boden, J. A., Boden, R., Begent, R. H.
Publicado 1994

Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.

por Sharma, S. K., Bagshawe, K. D., Burke, P. J., Boden, R. W., Rogers, G. T.
Publicado 1990

Exposure to risperidone versus other antipsychotics and risk of osteoporosis‐related fractures: a population‐based study

por Clapham, E., Bodén, R., Reutfors, J., Svensson, T., Ramcharran, D., Qiu, H., Kieler, H., Bahmanyar, S.
Publicado 2019

Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study

por Persson, Jonas, Szalisznyó, K., Antoni, G., Wall, A., Fällmar, D., Zora, H., Bodén, R.
Publicado 2019

Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study

por Bodén, R, Persson, J, Wall, A, Lubberink, M, Ekselius, L, Larsson, E-M, Antoni, G
Publicado 2017

Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.

por Marshall, D., Pedley, R. B., Melton, R. G., Boden, J. A., Boden, R., Begent, R. H.
Publicado 1995

Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.

por Marshall, D., Pedley, R. B., Boden, J. A., Boden, R., Melton, R. G., Begent, R. H.
Publicado 1996

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.

por Pedley, R. B., Boden, J. A., Boden, R. W., Green, A., Boxer, G. M., Bagshawe, K. D.
Publicado 1989

The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.

por Pedley, R. B., Boden, J. A., Boden, R., Begent, R. H., Turner, A., Haines, A. M., King, D. J.
Publicado 1994

Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle.

por Casey, J. L., King, D. J., Pedley, R. B., Boden, J. A., Boden, R., Chaplin, L. C., Dorning, M., Begent, R. H.
Publicado 1998

Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.

por Turner, A., King, D. J., Farnsworth, A. P., Rhind, S. K., Pedley, R. B., Boden, J., Boden, R., Millican, T. A., Millar, K., Boyce, B.
Publicado 1994

Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification.

por Delgado, C., Pedley, R. B., Herraez, A., Boden, R., Boden, J. A., Keep, P. A., Chester, K. A., Fisher, D., Begent, R. H., Francis, G. E.
Publicado 1996